| |
| |
|
| Insider
Information: |
Gold Mitchell |
| Relationship: |
Executive Chairman and... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,263 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2008-05-21 |
5 |
GD |
$5.06 |
$32,890 |
D/D |
6,500 |
381,642 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2019-01-18 |
4 |
B |
$5.37 |
$1,024,999 |
I/I |
190,875 |
3,994,781 |
2.64 |
- |
|
| DNDN |
Dendreon Corp |
officerTitle |
• • – |
2006-01-19 |
4 |
A |
$5.50 |
$309,375 |
D/D |
56,250 |
107,183 |
|
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2005-03-18 |
4 |
B |
$5.64 |
$22,540 |
D/D |
4,000 |
50,511 |
2.74 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2005-01-31 |
5 |
S |
$5.78 |
$8,849 |
D/D |
(1,531) |
46,511 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2008-04-18 |
4 |
D |
$5.85 |
$3,621 |
D/D |
(619) |
389,071 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2008-04-19 |
4 |
D |
$5.85 |
$5,435 |
D/D |
(929) |
388,142 |
0 |
- |
|
| DNDN |
Dendreon Corp |
CEO |
• • – |
2003-09-03 |
4 |
A |
$6.32 |
$221,200 |
D/D |
35,000 |
35,000 |
|
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2008-01-18 |
4 |
D |
$6.43 |
$19,599 |
D/D |
(3,048) |
390,837 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2008-01-19 |
4 |
D |
$6.43 |
$7,375 |
D/D |
(1,147) |
389,690 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2012-06-30 |
4 |
D |
$7.40 |
$1,463,454 |
D/D |
(197,764) |
432,263 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2024-05-08 |
4 |
OE |
$7.55 |
$100,000 |
D/D |
13,245 |
109,245 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2007-10-19 |
4 |
D |
$7.62 |
$9,761 |
D/D |
(1,281) |
300,705 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2012-04-15 |
4 |
D |
$8.85 |
$25,603 |
D/D |
(2,893) |
631,883 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-10-17 |
4 |
D |
$9.31 |
$19,756 |
D/D |
(2,122) |
223,558 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-09-17 |
4 |
AS |
$9.40 |
$3,760,000 |
I/I |
(400,000) |
2,600,980 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-06-30 |
4 |
D |
$9.71 |
$79,884 |
D/D |
(8,227) |
60,634 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-10-15 |
4 |
D |
$9.75 |
$38,864 |
D/D |
(3,986) |
225,680 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-06-28 |
4 |
AS |
$10.00 |
$34,792 |
D/D |
(3,479) |
164,901 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-09-15 |
4 |
AS |
$10.00 |
$34,840 |
D/D |
(3,484) |
161,417 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-09-16 |
4 |
AS |
$10.00 |
$67,696 |
D/D |
(6,768) |
154,649 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-06-25 |
4 |
AS |
$10.01 |
$94,865 |
D/D |
(9,473) |
168,380 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-09-17 |
4 |
AS |
$10.01 |
$452,964 |
D/D |
(45,262) |
109,387 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-04-13 |
4 |
AS |
$10.07 |
$100,714 |
D/D |
(10,000) |
260,039 |
0 |
% |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2012-04-20 |
4 |
D |
$10.35 |
$9,594 |
D/D |
(927) |
630,956 |
0 |
- |
|
140 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
